Form 8-K - Current report:
SEC Accession No. 0000898432-24-000143
Filing Date
2024-02-21
Accepted
2024-02-21 16:20:32
Documents
15
Period of Report
2024-02-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 33721
  Complete submission text file 0000898432-24-000143.txt   233835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240215.xsd EX-101.SCH 5246
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240215_def.xml EX-101.DEF 19634
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240215_lab.xml EX-101.LAB 31018
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240215_pre.xml EX-101.PRE 21990
16 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 9618
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 24659820
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)